Currently holds positions in FibroGen Inc, Bio Rad Laboratories Inc and Clearside Biomedical Inc
Position | Company | Period |
---|---|---|
Independent Director | FibroGen Inc | Oct. 29, 2015 - |
Independent Director | Bio Rad Laboratories Inc | April 25, 2017 - |
Independent Director | Clearside Biomedical Inc | Sept. 26, 2018 - |
Chief Financial Officer, Principal Financial Officer, Executive Vice President - Finance and Business Development | Allergan Inc | Sept. 1, 2005 - Aug. 18, 2014 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-06-09 | 2023-06-09 |
FibroGen Inc
(FGEN)
|
PS Planned sale |
4,624
-12.0%
17.5180,966 USD |
4,624 -12.0% | 17.51 | 80,966 USD | |
2023-06-09 | 2023-06-09 |
FibroGen Inc
(FGEN)
|
PS Planned sale |
3,265
-7.8%
16.7454,656 USD |
3,265 -7.8% | 16.74 | 54,656 USD |